Monocarboxylate transporter 1 deficiency and ketone utilization
Publication year
2014Author(s)
Source
The New England Journal of Medicine, 371, 20, (2014), pp. 1900-7ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Ophthalmology
Human Genetics
Paediatrics - OUD tm 2017
Journal title
The New England Journal of Medicine
Volume
vol. 371
Issue
iss. 20
Page start
p. 1900
Page end
p. 7
Subject
Radboudumc 12: Sensory disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life SciencesAbstract
Ketoacidosis is a potentially lethal condition caused by the imbalance between hepatic production and extrahepatic utilization of ketone bodies. We performed exome sequencing in a patient with recurrent, severe ketoacidosis and identified a homozygous frameshift mutation in the gene encoding monocarboxylate transporter 1 (SLC16A1, also called MCT1). Genetic analysis in 96 patients suspected of having ketolytic defects yielded seven additional inactivating mutations in MCT1, both homozygous and heterozygous. Mutational status was found to be correlated with ketoacidosis severity, MCT1 protein levels, and transport capacity. Thus, MCT1 deficiency is a novel cause of profound ketoacidosis; the present work suggests that MCT1-mediated ketone-body transport is needed to maintain acid-base balance.
This item appears in the following Collection(s)
- Academic publications [232014]
- Electronic publications [115251]
- Faculty of Medical Sciences [89012]
- Open Access publications [82628]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.